Form 4: Retractable Technologies CEO Thomas Shaw Increases Stake Through Open Market Purchase
Insider Transaction Report
Retractable Technologies Inc.'s President and CEO, Thomas J. Shaw, acquired 1,347 shares of common stock at a weighted average price of $0.6221 per share, increasing his direct beneficial ownership to over 15.4 million shares.
Summary
- Thomas J. Shaw, who serves as President and CEO, Director, and 10% Owner of Retractable Technologies Inc. (RVP), purchased 1,347 shares of the company's common stock.
- The transaction occurred on June 30, 2025, with the shares acquired at a weighted average price of $0.6221 per share.
- Following this acquisition, Mr. Shaw directly beneficially owns 15,442,020 shares of common stock.
- Mr. Shaw also indirectly beneficially owns an additional 831,600 shares, which includes investment power over 500,000 shares as Trustee for the benefit of a family member and voting control over the remainder through a voting agreement.
- This purchase was executed pursuant to a Rule 10b5-1 plan, which was adopted on August 22, 2024.
Sentiment
Score: 8
Explanation: The insider purchase by the CEO, who is also a 10% owner and director, is a strong positive signal, indicating high confidence in the company's future. The transaction being part of a 10b5-1 plan also suggests a pre-meditated investment strategy.
Positives
- The purchase of shares by Thomas J. Shaw, the President and CEO, Director, and 10% Owner, signals strong insider confidence in Retractable Technologies Inc.'s future prospects and valuation.
- The transaction was conducted under a pre-arranged Rule 10b5-1 plan, adopted on August 22, 2024, indicating a strategic and planned investment.
Industry Context
The transaction reflects an insider's continued investment in Retractable Technologies Inc., a company operating in the medical device sector, specifically known for its safety syringe technology. While this filing does not provide broader industry trends, insider purchases can signal management's confidence in the company's position within its market.
Related Party Transactions
- Mr. Shaw has indirect beneficial ownership of 831,600 shares, including investment power over 500,000 shares as Trustee for the benefit of a family member, which constitutes a related party arrangement regarding beneficial ownership.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive indicator of future stock performance and management's belief in the company's value.
Key Dates
| Date | Description |
|---|---|
| 2024-08-22 | Date of adoption of the Rule 10b5-1 Plan. |
| 2025-06-30 | Date of the common stock transaction (purchase of 1,347 shares). |
| 2025-07-01 | Date the Form 4 was signed by D. Valerie Thomas, Attorney-in-Fact for Thomas J. Shaw. |
Recommendation
buyKeywords
Retractable Technologies Inc., RVP, Thomas J. Shaw, Insider Buying, CEO Stock Purchase, SEC Form 4, Beneficial Ownership, Rule 10b5-1 Plan, Medical Devices, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.